| abstract |
The present invention relates to an anticancer composition and a cancer treatment kit containing N, N-dimethylphytosphingosine as an active ingredient. Since the anticancer agent composition according to the present invention can suppress the activity of sphingosine kinase, it can block many mechanisms induced by sphingosine kinase. For example, high levels of ceramide and sphingosine can be maintained by preventing sphingosine from phosphorylating by sphingokinase, and apoptosis is induced from cancer cells by these ceramide and sphingosine, thus killing cancer cells There is an effect. |